Andrew John Phillips - Jun 5, 2025 Form 4 Insider Report for MoonLake Immunotherapeutics (MLTX)

Role: Director
Signature: /s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips
Stock symbol: MLTX
Transactions as of: Jun 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/9/2025, 09:05 AM
Previous filing: May 30, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Phillips Andrew John	Director	C/O MOONLAKE IMMUNOTHERAPEUTICS, DORFSTRASSE 29, ZUG, SWITZERLAND	/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips	2025-06-09	0001921956

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MLTX	Option to Buy	Award	$0	+6.68K		$0.00	6.68K	Jun 5, 2025	Class A ordinary shares, par value $0.0001 per share	6.68K	$48.83	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.